Skip to content

BI 201335 & BI 207127 and ribavirin shows good efficacy, including hepatitis C patients with cirrhosis

Strengthening TB laboratory capacity to support active case finding

US regulators vote for approval of PrEP by large majority

Canadian cohort shows viral suppression most likely with atazanavir/ritonavir-based HIV treatment after 6 months

Ribavirin dose reduction is effective for managing anaemia in patients using boceprevir or telaprevir

HIV treatment reduces incidence of pre-cancerous cervical lesions and promotes their regression

Promising findings for therapeutic hepatitis C vaccine TG4040

Depression and pegylated interferon: doctors look at screening strategies and treatment

Black race and depression associated with poorer adherence to HIV treatment